December 11th, 2017
jobs
homes

Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Silence Therapeutics Plc - American Depository Share (NQ:SLN)

4.930 -0.380 (-7.16%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 27, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Silence Therapeutics Plc - American Depository Share

< Previous 1 2 3 Next >
Top stock movements in today's session. ↗
Via Chartmill
Keep an eye on the top gainers and losers in Friday's session. ↗
Via Chartmill
Which stocks are gapping on Friday? ↗
Via Chartmill
Top movers analysis one hour before the close of the markets on 2026-03-26: top gainers and losers in today's session. ↗
Via Chartmill
News headline image
Deep Dive Into Silence Therapeutics Stock: Analyst Perspectives (7 Ratings) ↗
 
Via Benzinga
News headline image
Earnings Scheduled For February 27, 2025 ↗
 
Via Benzinga
News headline image
Deep Dive Into Silence Therapeutics Stock: Analyst Perspectives (7 Ratings) ↗
 
Via Benzinga
News headline image
The Analyst Landscape: 6 Takes On Silence Therapeutics ↗
 
Via Benzinga
Here are the top movers in Thursday's session. ↗
Via Chartmill
These stocks that are showing activity before the opening bell on Thursday. ↗
Via Chartmill
Top movers in Friday's session ↗
Via Chartmill
Which stocks are moving on Thursday? ↗
Via Chartmill
News headline image
Analyst Scoreboard: 4 Ratings For Silence Therapeutics ↗
 
Via Benzinga
News headline image
Analyst Expectations For Silence Therapeutics's Future ↗
 
Via Benzinga
Get insights into the top gainers and losers of Thursday's pre-market session. ↗
Via Chartmill
News headline image
Bausch Health’s Slow Rebuild Faces New Scrutiny After Lombard Odier Cuts Its Stake ↗
Bausch Health’s valuation suggests potential, but the stake cut shows how far the company still has to go to earn back full investor confidence. 
Via The Motley Fool
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Silence (SLN) Q2 Revenue Drops 71% ↗
Via The Motley Fool
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
Via Benzinga
News headline image
These stocks are moving in today's pre-market session ↗
Discover the top movers in Tuesday's pre-market session and stay informed about market dynamics. 
Via Chartmill
News headline image
Wall Street's Top 10 Stock Calls This Week - Saturday, Feb. 15 ↗
What has Wall Street been buzzing about this week? Here is a look at the top 5 buy calls and the top 5 sell calls made by Wall Street's best analysts during the trading week of Feb. 10-14, 2025. 
Via Talk Markets
Topics Stocks / Equities
News headline image
This IBM Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday ↗
 
Via Benzinga
News headline image
Top 3 Health Care Stocks That May Explode In Q4 ↗
 
Via Benzinga
News headline image
Silence Therapeutics' Zerlasiran Has Competitive Concerns: Analyst ↗
Silence Therapeutics' Phase 2 data shows zerlasiran achieves over 80% Lp(a) reduction in ASCVD patients but faces dosing frequency challenges. 
Via Benzinga
News headline image
Top 3 Health Care Stocks You'll Regret Missing In Q4 ↗
 
Via Benzinga
News headline image
SLN Stock Earnings: Silence Therapeutics Reported Results for Q2 2024 ↗
Silence Therapeutics just reported results for the second quarter of 2024. 
Via InvestorPlace
News headline image
The 3 Best Gene Editing Stocks to Buy in August 2024 ↗
These are the best gene-editing stocks to buy as the biotechs pursue precision therapies to cure rare diseases. 
Via InvestorPlace
News headline image
Morgan Stanley Predicts Triple-Digit Rally for These 3 Stocks ↗
It takes a special set of circumstances for high-growth stocks to double in value in one year but analyst says these three can do it. 
Via InvestorPlace
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

More ways to get to us

Lethbridge Herald Facebook Facebook
Lethbridge Herald Twitter Twitter
Lethbridge Herald YouTube YouTube

About Us

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

© 1996-2017 The Lethbridge Herald, A Division of Continental Newspapers Canada Ltd.